Kahn Sagol Maccabi Explained
The Kahn-Sagol-Maccabi for Research and Innovation |
Native Name: | Hebrew: מכון קאהן-סגול-מכבי למחקר ולחדשנות (Hebrew) |
Type: | Medical research |
Established: | 2016 |
Country: | Israel |
The Kahn-Sagol-Maccabi (KSM) for Research and Innovation (in Hebrew: מכון קאהן-סגול-מכבי למחקר ולחדשנות) is the Research and Innovation Center of Maccabi Healthcare Services.[1]
History
Founded in 2016 by Maccabi Health Services with the key support of Morris Kahn and Sami Sagaol, KSM promotes excellence in medical research.[2]
It wasa formerly headed by Prof. Varda Shalev and is currently headed by Dr. Tal Patalon.[3]
Activities and services
Medical studies
KSM Center strives to enhance healthcare systems through independent research and partnerships with international researchers,[4] academic institutions, pharmaceutical companies, start-ups and technology firms.[5] [6]
Since its inception, the center has conducted hundreds of studies,[7] resulting in the development of tools for both patients and healthcare providers.[8] These studies have influenced medical policies in several countries, particularly during the COVID-19 pandemic.[9]
Notable studies conducted under KSM's auspices include:
- Studies on the coronavirus epidemic – During the COVID-19 pandemic, several international scientific studies based on the Maccabi databases were conducted by the center, Including studies on repeated infection in children,[10] repeated infection in adults,[11] natural vaccination,[12] reduction of transmission[13] the decline in the effect of the third vaccine[14] the effect of the vaccine on intra-domestic infection[15] and on patients with Coeliac disease.[16]
- Research on mpox – In 2023, a study on mpox based on KSM's analysis and database was published.[17]
- Research on Parvovirus B19 – In 2023, a study on a local outbreak of parvovirus was published.[18]
- Research on autism – In 2023, a study on late diagnosis of autism was published.[19]
- Research on cancer – In 2023, a study of the effects of palbociclib treatment on the lifespan of patients with breast cancer was published.[20]
Medical database
KSM's research activities are based on independent efforts, as well as the extensive medical knowledge and database of Maccabi Health Services.[21] This database, compiled over three decades and anonymized, encompasses digital records of 2.7 million insured individuals.[22]
In addition to its in-house research,[23] the Center offers global researchers access to conduct studies, analyses [30] and medical prediction,[24] based on this comprehensive database.[25]
KSM's innovation and big data department leverages databases and artificial intelligence technologies,[26] [27] facilitating a wide range of research opportunities, analysis and medical prediction.[28]
Biobank
The KSM Center has established the Tipa BioBank,[29] Israel's largest biobank[30] housing over a million genetic samples for research purposes.[31]
The purpose of this initiative is to develop tools for early disease detection through genetic[32] and biological studies.[33] A central feature of this effort is the creation of a repository of biological samples (e.g., blood, urine, etc.), enabling researchers to investigate how genetic profiles influence disease risk and treatment.[34]
Main publications
- 10.1016/S2666-5247(23)00103-9 . Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: A target trial emulation . 2023 . Gazit . Sivan . Saciuk . Yaki . Perez . Galit . Peretz . Asaf . Ben-Tov . Amir . Stuart . Elizabeth A. . Patalon . Tal . The Lancet Microbe . 4 . 7 . e495–e505 . 37062294 . 10101759 .
- 10.3390/v15040855. free . Immunosuppression as a Hub for SARS-CoV-2 Mutational Drift . 2023 . Shapira . Guy . Patalon . Tal . Gazit . Sivan . Shomron . Noam . Viruses . 15 . 4 . 855 . 37112835 . 10145566 .
- 10.1016/j.jpeds.2023.02.016 . Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents . 2023 . Patalon . Tal . Saciuk . Yaki . Perez . Galit . Peretz . Asaf . Ben-Tov . Amir . Gazit . Sivan . The Journal of Pediatrics . 257 . 36870558 . 9981270 .
- 10.1093/cid/ciac262 . Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study . 2022 . Gazit . Sivan . Shlezinger . Roei . Perez . Galit . Lotan . Roni . Peretz . Asaf . Ben-Tov . Amir . Herzel . Esma . Alapi . Hillel . Cohen . Dani . Muhsen . Khitam . Chodick . Gabriel . Patalon . Tal . Clinical Infectious Diseases . 75 . 1 . e545–e551 . 35380632 . 9047157 .
- 10.7326/M21-4130 . The Incidence of SARS-CoV-2 Reinfection in Persons with Naturally Acquired Immunity with and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine . 2022 . Gazit . Sivan . Shlezinger . Roei . Perez . Galit . Lotan . Roni . Peretz . Asaf . Ben-Tov . Amir . Herzel . Esma . Alapi . Hillel . Cohen . Dani . Muhsen . Khitam . Chodick . Gabriel . Patalon . Tal . Annals of Internal Medicine . 175 . 5 . 674–681 . 35157493 . 8855786 .
- 10.3390/v15091968. free . BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign . 2023 . Ben-Tov . Amir . Lebwohl . Benjamin . Banon . Tamar . Chodick . Gabriel . Kariv . Revital . Assa . Amit . Gazit . Sivan . Patalon . Tal . Viruses . 15 . 9 . 1968 . 37766374 . 10534420 .
- 10.1111/apt.16282 . Increased incidence of coeliac disease autoimmunity rate in Israel: A 9-year analysis of population-based data . 2021 . Lechtman . Niva . Shamir . Raanan . Cohen . Shlomi . Chodick . Gabriel . Kariv . Revital . Supino-Rosin . Lia . Weintraub . Yael . Yerushalmy-Feler . Anat . Ben Tov . Amir . Alimentary Pharmacology & Therapeutics . 53 . 6 . 696–703 . 33547687 . 231946967 .
Notes and References
- https://www.ksminnovation.com/ The Kahn-Sagol-Maccabi (KSM) Institute for Research and Innovation
- Web site: Kahn Sagol Maccabi . Guidestar . 9 November 2023.
- https://www.maccabi4u.co.il/32342-he/Maccabi.aspx Big data unit
- Neesha Salian, SEHA and Israel’s leading HMO announce collaboration in research and digital health development, Gulf Business, 13 July 2022
- https://www.accesswire.com/721905/Maccabis-KSM-Research-and-Innovation-Center-Announces-Partnership-with-Rhino-Health-to-Facilitate-Healthcare-Data-Collaborations Maccabi’s KSM Research and Innovation Center Announces Partnership with Rhino Health to Facilitate Healthcare Data Collaborations
- https://www.360dx.com/cancer/prognomiq-maccabi-health-collaborating-cancer-biomarker-development PrognomiQ, Maccabi Health Collaborating on Cancer Biomarker Development
- https://www.ksminnovation.com/publications/ Professional publications
- News: Rubinstein . Carrie . Small-Big Data: A Healthcare Revolution In The Making . 26 October 2023 . . 9 September 2022.
- 10.1016/j.jpeds.2023.02.016 . Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents . 2023 . Patalon . Tal . Saciuk . Yaki . Perez . Galit . Peretz . Asaf . Ben-Tov . Amir . Gazit . Sivan . The Journal of Pediatrics . 257 . 36870558 . 9981270 .
- 10.1016/S2666-5247(23)00103-9 . Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: A target trial emulation . 2023 . Gazit . Sivan . Saciuk . Yaki . Perez . Galit . Peretz . Asaf . Ben-Tov . Amir . Stuart . Elizabeth A. . Patalon . Tal . The Lancet Microbe . 4 . 7 . e495–e505 . 37062294 . 10101759 .
- 35157493 . 2022 . Gazit . S. . Shlezinger . R. . Perez . G. . Lotan . R. . Peretz . A. . Ben-Tov . A. . Herzel . E. . Alapi . H. . Cohen . D. . Muhsen . K. . Chodick . G. . Patalon . T. . The Incidence of SARS-CoV-2 Reinfection in Persons with Naturally Acquired Immunity with and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine: A Retrospective Cohort Study . Annals of Internal Medicine . 175 . 5 . 674–681 . 10.7326/M21-4130 . 8855786 .
- Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents . 10.1016/j.jpeds.2023.02.016 . 2023 . Patalon . Tal . Saciuk . Yaki . Perez . Galit . Peretz . Asaf . Ben-Tov . Amir . Gazit . Sivan . The Journal of Pediatrics . 257 . 36870558 . 9981270 .
- van Boven . Michiel . van Dorp . Christiaan H. . Westerhof . Ilse . Jaddoe . Vincent . Heuvelman . Valerie . Duijts . Liesbeth . Fourie . Elandri . Sluiter-Post . Judith . van Houten . Marlies A. . Badoux . Paul . Euser . Sjoerd . Herpers . Bjorn . Eggink . Dirk . de Hoog . Marieke . Boom . Trisja . Wildenbeest . Joanne . Bont . Louis . Rozhnova . Ganna . Bonten . Marc J. . Kretzschmar . Mirjam E. . Bruijning-Verhagen . Patricia . 3. Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study . PLOS Computational Biology . 20 . 1 . 29 January 2024 . 1553-7358 . 38285727 . 10852262 . 10.1371/journal.pcbi.1011832 . free . e1011832. 10.1101/2023.06.02.23290879.
- 10.1038/s41467-022-30884-6 . Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine . 2022 . Patalon . Tal . Saciuk . Yaki . Peretz . Asaf . Perez . Galit . Lurie . Yoav . Maor . Yasmin . Gazit . Sivan . Nature Communications . 13 . 1 . 3203 . 35680872 . 9184525 . 2022NatCo..13.3203P .
- Prunas . Ottavia . Warren . Joshua L. . Crawford . Forrest W. . Gazit . Sivan . Patalon . Tal . Weinberger . Daniel M. . Pitzer . Virginia E. . 2022 . Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel . Science . 375 . 6585 . 1151–1154 . 2022Sci...375.1151P . 10.1126/science.abl4292 . 9261115 . 35084937.
- 10.3390/v15091968. free . BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign . 2023 . Ben-Tov . Amir . Lebwohl . Benjamin . Banon . Tamar . Chodick . Gabriel . Kariv . Revital . Assa . Amit . Gazit . Sivan . Patalon . Tal . Viruses . 15 . 9 . 1968 . 37766374 . 10534420 .
- 10.3390/microorganisms11041042. free . Mpox Patient Journey in Israel . 2023 . Patalon . Tal . Perez . Galit . Saciuk . Yaki . Refaeli . Ziva . Gazit . Sivan . Microorganisms . 11 . 4 . 1042 . 37110465 . 10145053 .
- 10.3390/v15112261. free . An Outbreak of Parvovirus B19 in Israel . 2023 . Patalon . Tal . Saciuk . Yaki . Trotzky . Daniel . Pachys . Gal . Ben-Tov . Amir . Segal . Yaakov . Gazit . Sivan . Viruses . 15 . 11 . 2261 . 38005937 . 10674631 .
- 10.1002/aur.2869 . Late diagnosis of autism spectrum disorder—Journey, parents' concerns, and sex influences . 2023 . Davidovitch . Michael . Gazit . Sivan . Patalon . Tal . Leitner . Yael . Rotem . Ran S. . Autism Research . 16 . 2 . 294–301 . 36495248 . 254561408 .
- 10.2217/fon-2023-0176 . Real-world outcomes of patients with metastatic endocrine-responsive breast cancer receiving palbociclib-based combinations . 2023 . Moser . Sarah Sharman . Mazursky . Orr Friedman . Shalev . Hadas . Apter . Lior . Chodick . Gabriel . Siegelmann-Danieli . Nava . Future Oncology . 19 . 21 . 1473–1483 . 37529919 . free .
- Valo Health, KSM research and innovation center and Valo health announce first of its kind multiyear collaboration to spearhead preventive care and personalized medicine for patients, 19 Sep 2022
- News: Kraus . Yair . "Artificial intelligence is going to lead to a change the likes of which we haven't seen in years in the world of medicine" . 9 November 2023 . . 1 August 2023.
- News: Yanko . Adir . A significant increase in the diagnosis of young celiac patients in Israel – what are the reasons for this? . 26 October 2023 . . 25 March 2021.
- 10.1016/S2213-2600(22)00407-6. Safety of the fourth COVID-19 BNT162b2 mRNA (Second booster) vaccine: A prospective and retrospective cohort study. 2023. Yechezkel. Matan. Mofaz. Merav. Painsky. Amichai. Patalon. Tal. Gazit. Sivan. Shmueli. Erez. Yamin. Dan. The Lancet Respiratory Medicine. 11. 2. 139–150. 36410364. 9889528.
- News: Weinerb . Gali . Predicting illnesses and hospitalizations: the vision of the director of the Maccabi Research Institute . 26 October 2023 . . 1 December 2020.
- Danny Sullivan, Longevity AI partners with Israel’s leading HMO, Technology, 4 April 2023
- https://aithority.com/medical-apps/healthcare-management/ibex-introduces-galen-gastric-worlds-first-ai-powered-solution-for-gastrointestinal-cancer-diagnostics-at-maccabi-healthcare-services/ IBEX Introduces Galen Gastric, World’s First AI-Powered Solution For Gastrointestinal Cancer Diagnostics, At Maccabi Healthcare Services
- News: Suresh . Somasetty . New Study Shows Pfizer COVID-19 Vaccine Equally Effective for Patients with Celiac Disease . 26 October 2023 . Express Healthcare Management . 25 October 2023.
- https://www.ksminnovation.com/activity/biobank/ The Tipa Biobank
- https://www.ushealthcarejournal.com/article/586091878-ksm-research-and-innovation-and-genetika-partner-to-seek-ai-solutions-for-personalization-of-depression-treatment KSM Research And Innovation And Genetika+ Partner To Seek AI Solutions For Personalization Of Depression Treatment
- News: 1 February 2023 . Abu Dhabi DoH and Kahn Sagol Maccabi (KSM) Sign an MoU to Cooperate in Technological Innovation and Healthcare Research . 26 October 2023 . AP news.
- https://www.arabianbusiness.com/gcc/uae/g42-healthcare-ksm-enter-first-uae-israel-genetic-research-collaboration G42 Healthcare, KSM enter first UAE-Israel genetic research collaboration – Arabian Business
- News: Rubinstein . Carrie . 12 July 2023 . Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare . 26 October 2023 . Forbes.
- https://www.middleeastmonitor.com/20220714-israel-and-uae-to-collaborate-on-cancer-and-diabetes-research/ Israel and UAE to collaborate on cancer and diabetes research